Organization
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
8 abstracts
2 posters
Abstract
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Nagoya City University Graduate School of Medical Sciences, Imamura General Hospital, Kumamoto University Hospital, Kindai University Faculty of Medicine, Osaka-Sayama, Japan,
Abstract
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Disaster Medical Center, Tokyo, Japan, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Innovation of the first-line strategy optimized as abemaciclib with endocrine therapy based on the ESR1 mutation of ctDNA for patients with HR-positive HER2-negative advanced metastatic breast cancer (JBCRG-M08; AMBER study).Org: Osaka University Hospital, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), Nagoya University Hospital,
Abstract
Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.Org: National Cancer Center Hospital East, Kashiwa, Japan, Cancer Chemotherapy Center, Department of Surgery, Brigham and Women's Hospital, Boston, MA, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan, Natera, Inc.,
Abstract
Efficacy and safety of futibatinib for refractory advanced solid malignancies with FGFR alterations identified in circulating tumor DNA: TiFFANY, A GOZILA-affiliated Trial.Org: Munakata Medical Association Hospital, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, Aichi Cancer Center Hospital, National Hospital Organization Osaka National Hospital, National Hospital Organization Shikoku Cancer Center,
Abstract
Radiation therapy (RT)-free pembrolizumab plus chemotherapy (P+C) for PD-L1 TPS ≥50% locally advanced non-small cell lung cancer (LA-NSCLC): An early report analyzing depth of response from multicenter single arm phase II study (Evolution trial: WJOG11819L).Org: Kobe Minimally Invasive Cancer Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan, Takarazuka City Hospital, Hyogo Medical University, Kurashiki Central Hospital, Kurashiki, Japan,
Abstract
Large-scale comparative analysis of clinico-genomic characteristics, treatment outcomes and resistant mechanisms of ALK/ROS1/RET-rearranged non-small cell lung cancer (NSCLC) in a nationwide genomic screening project (LC-SCRUM-Asia/TRY).Org: National Cancer Center Hospital East, Kashiwa, Japan, Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Osaka International Cancer Institute, Osaka, Japan, Sendai Kousei Hospital,
Abstract
AORTIC INFLAMMATION IN PATIENTS WITH SYSTEMIC INFLAMMATORY DISEASESOrg: Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, Surgical Department, Lillehammer Hospital for rheumatic diseases, Feiringklinikken, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,